Recombinant human erythropoietin (rHuEPO) has revolutionized anemia management, as it reduces the need for red blood cell (RBC) transfusions and improves anemia-related symptoms and quality of life [2,3]. The gene discussed is EPO; the disease is anemia (phenotype).